iCoreConnect Inc. (ICCT)
USD 2.77
(1.08%)
USD 2.77
(1.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.15 Million USD | 2.05% |
| 2022 | 7.98 Million USD | 61.16% |
| 2021 | 4.95 Million USD | 133.4% |
| 2020 | 2.12 Million USD | 109.43% |
| 2019 | 1.01 Million USD | -6.89% |
| 2018 | 1.08 Million USD | 66.77% |
| 2017 | 653 Thousand USD | 0.0% |
| 2014 | 366.44 Thousand USD | 246.71% |
| 2013 | 105.69 Thousand USD | -82.25% |
| 2012 | 595.5 Thousand USD | 35.92% |
| 2011 | 438.12 Thousand USD | 165.32% |
| 2010 | 165.13 Thousand USD | -52.42% |
| 2009 | 347.09 Thousand USD | -41.04% |
| 2008 | 588.69 Thousand USD | -37.49% |
| 2007 | 941.75 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 3.08 Million USD | 13.39% |
| 2024 Q1 | 2.72 Million USD | 11.15% |
| 2023 FY | 8.15 Million USD | 2.05% |
| 2023 Q3 | 2 Million USD | 8.01% |
| 2023 Q4 | 2.45 Million USD | 22.21% |
| 2023 Q2 | 1.85 Million USD | 0.86% |
| 2023 Q1 | 1.84 Million USD | -9.97% |
| 2022 Q2 | 2.01 Million USD | -1.6% |
| 2022 Q1 | 2.04 Million USD | 7.23% |
| 2022 FY | 7.98 Million USD | 61.16% |
| 2022 Q4 | 2.04 Million USD | 8.22% |
| 2022 Q3 | 1.88 Million USD | -6.09% |
| 2021 Q2 | 981.37 Thousand USD | 39.4% |
| 2021 Q1 | 704 Thousand USD | 14.36% |
| 2021 FY | 4.95 Million USD | 133.4% |
| 2021 Q4 | 1.9 Million USD | 39.63% |
| 2021 Q3 | 1.36 Million USD | 39.1% |
| 2020 Q4 | 615.58 Thousand USD | 16.15% |
| 2020 Q2 | 472 Thousand USD | -6.72% |
| 2020 FY | 2.12 Million USD | 109.43% |
| 2020 Q1 | 506 Thousand USD | 148.04% |
| 2020 Q3 | 530 Thousand USD | 12.29% |
| 2019 Q1 | 280 Thousand USD | 42.86% |
| 2019 Q3 | 225 Thousand USD | -26.23% |
| 2019 Q4 | 204 Thousand USD | -9.33% |
| 2019 FY | 1.01 Million USD | -6.89% |
| 2019 Q2 | 305 Thousand USD | 8.93% |
| 2018 Q1 | 351 Thousand USD | 172.09% |
| 2018 Q4 | 196 Thousand USD | -27.68% |
| 2018 Q3 | 271 Thousand USD | -0.37% |
| 2018 Q2 | 272 Thousand USD | -22.51% |
| 2018 FY | 1.08 Million USD | 66.77% |
| 2017 Q4 | 129 Thousand USD | 13.16% |
| 2017 Q2 | 170 Thousand USD | -3.95% |
| 2017 Q1 | 177 Thousand USD | 0.0% |
| 2017 FY | 653 Thousand USD | 0.0% |
| 2017 Q3 | 114 Thousand USD | -32.94% |
| 2015 Q1 | 160.85 Thousand USD | 61.97% |
| 2014 FY | 366.44 Thousand USD | 246.71% |
| 2014 Q2 | -611.03 Thousand USD | -248.29% |
| 2014 Q1 | 412.04 Thousand USD | 7.83% |
| 2014 Q4 | 99.3 Thousand USD | -31.8% |
| 2014 Q3 | 145.61 Thousand USD | 123.83% |
| 2013 Q3 | 183.32 Thousand USD | 358.24% |
| 2013 Q4 | 382.11 Thousand USD | 108.43% |
| 2013 FY | 105.69 Thousand USD | -82.25% |
| 2013 Q1 | 36.33 Thousand USD | 92.73% |
| 2013 Q2 | 40 Thousand USD | 10.11% |
| 2012 Q3 | 10.5 Thousand USD | 125.13% |
| 2012 Q4 | 18.85 Thousand USD | 79.54% |
| 2012 FY | 595.5 Thousand USD | 35.92% |
| 2012 Q1 | 284.94 Thousand USD | 75.11% |
| 2012 Q2 | -41.78 Thousand USD | -114.67% |
| 2011 Q3 | 189.22 Thousand USD | 540.18% |
| 2011 Q1 | 136.47 Thousand USD | -53.9% |
| 2011 Q4 | 162.72 Thousand USD | -14.0% |
| 2011 Q2 | -42.98 Thousand USD | -131.5% |
| 2011 FY | 438.12 Thousand USD | 165.32% |
| 2010 FY | 165.13 Thousand USD | -52.42% |
| 2010 Q2 | 28.34 Thousand USD | 427.66% |
| 2010 Q1 | 5372.00 USD | -91.81% |
| 2010 Q4 | 296.03 Thousand USD | 509.16% |
| 2010 Q3 | 48.59 Thousand USD | 71.44% |
| 2009 Q4 | 65.58 Thousand USD | -0.38% |
| 2009 FY | 347.09 Thousand USD | -41.04% |
| 2009 Q3 | 65.83 Thousand USD | 22.18% |
| 2009 Q2 | 53.87 Thousand USD | -59.09% |
| 2009 Q1 | 131.7 Thousand USD | 66.4% |
| 2008 Q4 | 79.15 Thousand USD | 2.91% |
| 2008 Q3 | 76.91 Thousand USD | -36.11% |
| 2008 Q1 | 160.74 Thousand USD | -66.11% |
| 2008 Q2 | 120.38 Thousand USD | -25.11% |
| 2008 FY | 588.69 Thousand USD | -37.49% |
| 2007 Q2 | 9694.00 USD | -97.19% |
| 2007 Q3 | 166.71 Thousand USD | 1619.8% |
| 2007 FY | 941.75 Thousand USD | 0.0% |
| 2007 Q4 | 474.28 Thousand USD | 184.48% |
| 2007 Q1 | 345.53 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accolade, Inc. | 414.29 Million USD | 98.032% |
| Augmedix, Inc. | 44.85 Million USD | 81.827% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.908% |
| CareCloud, Inc. | 117.05 Million USD | 93.036% |
| CareCloud, Inc. | 117.05 Million USD | 93.036% |
| Definitive Healthcare Corp. | 251.41 Million USD | 96.758% |
| Health Catalyst, Inc. | 295.93 Million USD | 97.246% |
| HealthEquity, Inc. | 999.58 Million USD | 99.185% |
| HealthStream, Inc. | 279.06 Million USD | 97.079% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 98.779% |
| Nutex Health, Inc. | 247.64 Million USD | 96.708% |
| Omnicell, Inc. | 1.14 Billion USD | 99.289% |
| OneMedNet Corporation | 1.02 Million USD | -697.884% |
| Progyny, Inc. | 1.08 Billion USD | 99.251% |
| Renalytix Plc | 2.28 Million USD | -256.12% |
| Schrödinger, Inc. | 216.66 Million USD | 96.238% |
| Simulations Plus, Inc. | 70.01 Million USD | 88.357% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | 63.925% |
| SOPHiA GENETICS SA | 62.37 Million USD | 86.93% |
| Ontrak, Inc. | 12.74 Million USD | 36.031% |
| Minerva Surgical, Inc. | 50.29 Million USD | 83.792% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.958% |
| Sharecare, Inc. | 445.25 Million USD | 98.169% |
| Aclarion, Inc. | 75.4 Thousand USD | -10710.549% |
| CareMax, Inc. | 751.1 Million USD | 98.915% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -12440.902% |
| Forian Inc. | 20.48 Million USD | 60.2% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -12440.902% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 95.976% |
| SCWorx Corp. | 3.8 Million USD | -114.237% |
| 10x Genomics, Inc. | 618.72 Million USD | 98.683% |
| Zhongchao Inc. | 19.43 Million USD | 58.055% |
| MSP Recovery, Inc. | 7.7 Million USD | -5.796% |
| R1 RCM Inc. | 2.25 Billion USD | 99.638% |
| Spok Holdings, Inc. | 139.02 Million USD | 94.137% |
| Privia Health Group, Inc. | 1.65 Billion USD | 99.508% |
| EUDA Health Holdings Limited | 3.7 Million USD | -119.929% |
| TruBridge, Inc. | 339.43 Million USD | 97.598% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.908% |
| Sharecare, Inc. | 445.25 Million USD | 98.169% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 98.914% |
| Premier, Inc. | 1.34 Billion USD | 99.395% |
| Certara, Inc. | 354.33 Million USD | 97.699% |
| GeneDx Holdings Corp. | 202.56 Million USD | 95.976% |
| Ontrak, Inc. | 12.74 Million USD | 36.031% |
| SHL Telemedicine Ltd. | 57.07 Million USD | 85.718% |
| CareCloud, Inc. | 117.05 Million USD | 93.036% |
| EUDA Health Holdings Limited | 3.7 Million USD | -119.929% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -1014.376% |
| CareMax, Inc. | 751.1 Million USD | 98.915% |
| Healthcare Triangle, Inc. | 33.2 Million USD | 75.449% |
| National Research Corporation | 148.58 Million USD | 94.514% |
| Aclarion, Inc. | 75.4 Thousand USD | -10710.549% |
| OptimizeRx Corporation | 71.52 Million USD | 88.603% |